Share your story with others:

MedicineNet appreciates your comment. Your comment may be displayed on the site and will always be published anonymously. Patient Comments FAQs


Tell us a bit about your background to make your comments more useful to other MedicineNet users.
(Optional)

Screen Name: *

Gender of Patient:Male Female

Age Range of Patient:

I am a: Patient Caregiver


Enter your Comment

* Screen Name will appear next to the published comment. Please do not include your full name or email address.

By submitting your comment, and other materials (collectively referred to as a "Submission") to MedicineNet, you grant MedicineNet permission to use, copy, transmit, publish, display, edit and modify your Submission in connection with its Web site. MedicineNet will not pay you for your Submission. You represent that you have all rights necessary for MedicineNet to use your Submission as set forth above.

Please keep these guidelines in mind when writing your comment:

  • Please make sure you address the question asked.
  • Due to the overwhelming number of comments received, not all comments will be published.
  • When selecting comments to publish, our staff will choose those that are educational and complement the topic. Please try to stay on topic.
  • Your comment may be edited. We would typically edit comments to make them clearer and more readable. We will remove personal information such as last names, email and web addresses, and other potentially harmful information.
  • We will not notify you if your comment has been published. We suggest that you check back on the topic article regularly.
  • We do not provide medical or healthcare advice, treatment, or diagnosis.

Thank you for participating!


I have read and agree to abide by the MedicineNet Terms and Conditions and the MedicineNet Privacy Policy (required).

To prevent our systems from spam, please complete the following prior to submitting your comment.




What is the treatment for brief psychotic disorder?

Given the brief duration of brief psychotic disorder, medications tend to be an important part of addressing many of its symptoms. The first line of treatment inclues atypical antipsychotics, for example:

  • risperidone (Risperdal),
  • olanzapine (Zyprexa),
  • quetiapine (Seroquel),
  • ziprasidone (Geodon),
  • aripiprazole (Abilify),
  • paliperidone (Invega),
  • asenapine (Saphris),
  • iloperidone (Fanapt),
  • urasidone (Latuda), and
  • clozapine (Clozaril).

The latter is rarely indicated specifically for the treatment of the brief psychotic disorder. This group of medications might cause weight gain, drowsiness, and changes ion blood sugar and cholesterol.

The first generation, or typical, antipsychotic medication also used for the treatment of schizophrenia, and includes medications like:

  • chlorpromazine (Thorazine),
  • haloperidol (Haldol),
  • fluphenazine (Prolixin),
  • thiothixene (Navane),
  • trifluoperazine (Stelazine),
  • perphenazine (Trilafon), and
  • thioridazine (Mellaril).

These are now known as "neuroleptics" because, while they tend to be effective in treating positive symptoms of psychosis (for example, paranoia or other delusions, hallucinations), many of the side effects they can cause affect the neurologic (nervous) system. Examples of such side effects are muscle stiffness or rigidity, jitteriness, tremors, and muscle twitches. These older medications are thought to be not as effective against so-called negative symptoms like catatonia.

Since people with brief psychotic disorder are at increased risk of also having depression, medications that address that symptom can be an important part of treatment. These include serotonergic medications like:

  • fluoxetine (Prozac),
  • sertraline (Zoloft),
  • paroxetine (Paxil),
  • citalopram (Celexa), and
  • escitalopram (Lexapro)

They are often prescribed because of their effectiveness and infrequent occurrence of side effects. Other antidepressant medications used to treat the depression that can be associated with brief psychotic disorder include:

  • venlafaxine (Effexor),
  • duloxetine (Cymbalta),
  • desvenlafaxine (Pristiq), and
  • bupropion (Wellbutrin).

Cognitive behavioral psychotherapy (CBT) has been found to be helpful in helping the brief psychotic disorder sufferer manage some of the symptoms of this illness. CBT is a form of psychotherapy that focuses on helping the person understand and ultimately better manage how their thoughts and behaviors affect each other.

Return to Brief Psychotic Disorder

Health Solutions From Our Sponsors